Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
about
Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.Vaccination with recombinant adenoviruses expressing the peste des petits ruminants virus F or H proteins overcomes viral immunosuppression and induces protective immunity against PPRV challenge in sheep.The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants.Contemporary approaches to designing and evaluating vaccines against Chlamydia.Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunityT cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines.Mucosal immunity induced by pneumococcal glycoconjugate.Use of adenoviral vectors as veterinary vaccines.Delivery of Chlamydia vaccines.Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus.Cancer immunotherapy: a paradigm shift for prostate cancer treatment.miR-466 is putative negative regulator of Coxsackie virus and Adenovirus Receptor.Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus.Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.The Gordon Wilson lecture: using genetic medicine to regenerate diseased organs and protect against the hostile environment.Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.
P2860
Q27481420-3D65A10D-1ACD-4C84-8F75-D61A15326DB8Q33889779-A3C88550-2FD8-4AAF-B216-0565B432D4BBQ34482074-296D9BAA-B1BA-49D7-8155-0562094723F7Q35042482-1A308649-7CC4-4E0D-9719-F593F3AE37CDQ35193566-F82FC5D1-4059-4FD3-81F6-6B144BEA23FAQ36086236-FC83C249-8987-423F-8D86-63EE9F896E53Q36170783-761403C5-222D-49FF-A8A8-D5BE1BF89612Q36260940-95572176-5522-4415-9ECA-2002D6B745CBQ36288927-026E7C99-EDEA-4C44-BDA3-AAE2880198C2Q36316798-FD8F438A-34B6-46FA-9DF9-5B1191777EF2Q37185010-997CB88E-F159-4D2D-8AE4-7E22F15A7C22Q38013964-259EA7DF-6AE7-40DC-9B9C-D0D304504439Q38929867-EE6F7BDF-7710-48A6-9169-A9E991E24B89Q39390000-7FBF0DC2-E331-4B67-89CA-964B6ADBEA28Q39797242-436F1536-DE4D-4BC2-909A-3A3569C6B80AQ40344509-0F0AF064-8E8B-45C7-8972-94F893C70BA8Q43070160-C53C5FC3-AC46-40AF-A658-94BA2675B98FQ51888314-8DCA19DB-3B61-4FD3-A658-742B410F67F9
P2860
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@ast
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@en
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@nl
type
label
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@ast
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@en
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@nl
prefLabel
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@ast
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@en
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@nl
P1476
Adenoviruses as vectors for delivering vaccines to mucosal surfaces.
@en
P2093
P304
P356
10.1016/S0168-1656(00)00314-X
P577
2000-09-01T00:00:00Z